As of Monday, the Nasdaq Composite index had tumbled more than 11% since the start of the year. The outlook for the economy ...

One factor that keeps some investors away from healthcare stocks is the sector's dearth of generous and reliable dividend payers. This stands to reason, as nearly every stage of drug development and ...

Amgen (AMGN) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.

Amgen (NASDAQ: NASDAQ:AMGN) announced that the U.S. Food and Drug Administration (FDA) has granted an expanded label approval ...

This multi-factor model seeks low volatility stocks that also have strong momentum and high net payout yields. AMGEN INC (AMGN) is a large-cap growth stock in the Biotechnology & Drugs industry.

with #1 stocks returning an average of +25% annually since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has moved 0.14% higher. As of now, Amgen holds a Zacks Rank of #3 (Hold).

As predicted by many analysts, economists, and investors, the sweeping tariffs announced by the Trump administration on ...

Deep-pocketed investors have adopted a bearish approach towards Amgen (NASDAQ:AMGN), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled ...

with #1 stocks contributing an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has remained steady. Amgen is currently a Zacks Rank #3 (Hold).

Last Friday, the three most widely followed benchmark indexes closed a losing week. The Nasdaq Composite, the S&P 500 and the Dow Jones Industrial Average declined 2.6%, 1.5% and 1%, respectively.

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take ...

Our analysis of options history for Amgen (NASDAQ:AMGN) revealed 19 unusual trades. Delving into the details, we found 26% of traders were bullish, while 63% showed bearish tendencies. Out of all ...